Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.

 

Virtual West Oncology Conference
25:11

Virtual West Oncology Conference

66 y/o Male With DLBCL: R-CHOP, Revlimid Upfront, Curative Options, R-GemOx, CAR-T, Relapse After ASCT

FEATURING Jason Chandler, Neha Mehta-Shah, Abdulraheem Yacoub, Carlos Bachier
  • 26 views
  • March 11, 2021
13:21

Virtual West Oncology Conference

72 y/o Female With High WBCs, Low Platelet Count & Cytopenia: Option of ASCT, ESA, Luspatercept, HMAs, Progression to Leukemia

FEATURING Jason Chandler, Neha Mehta-Shah, Abdulraheem Yacoub, Carlos Bachier
  • 91 views
  • March 11, 2021
10:41

Virtual West Oncology Conference

ASH Updates on CML: Pathogenesis and Outcomes, 1L Therapy Choices, Treatment Free Remission

FEATURING Abdulraheem Yacoub
  • 183 views
  • March 11, 2021
  • 1
15:01

Virtual West Oncology Conference

ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythropoiesis in LR-IR Disease? Is EFS Better With Pevonedistat+Aza vs. Aza Alone in HR-MDS? Should We Combine Ven+Aza?

FEATURING Jason Chandler
  • 125 views
  • March 11, 2021
17:39

Virtual West Oncology Conference

2021 Update on Breast Cancer Brain Metastases: Current Treatment Options and Challenges

FEATURING Lee Schwartzberg
  • 275 views
  • March 10, 2021
  • 2
22:48

Virtual West Oncology Conference

40 y/o Premenopausal Woman With HR+ eBC: What Is the Best Local Therapy? Should We Use Genomic Assay to Aid Decision? How Should We Approach Symptom Control After Ovarian Suppression+Anastrozole?

FEATURING Lee Schwartzberg, Neelima Vidula, Terry Mamounas, Kristina Mirabeau-Beale, Jane Meisel, Gregory Vidal
  • 18 views
  • March 9, 2021
14:33

Virtual West Oncology Conference

59 y/o Woman With HER+ eBC: Neoadjuvant Chemo, Post-neoadjuvant Systemic Treatment/RT, CNS & Liver Metastases

FEATURING Lee Schwartzberg, Neelima Vidula, Terry Mamounas, Kristina Mirabeau-Beale, Jane Meisel, Gregory Vidal
  • 130 views
  • March 9, 2021
16:11

Virtual West Oncology Conference

Genomic Expression Panels for Chemo in eBC: Does Adjuvant Chemo Show IDFS Benefit in ER+/HER2- Patients? Is ET Useful? How Can We Use RSClin Score to Individualize Prognosis? When Can We Safely Omit Chemo?

FEATURING Terry Mamounas
  • 135 views
  • March 9, 2021
  • 1
16:46

Virtual West Oncology Conference

2021 Updates on mTNBC: Do Olaparib/Talazoparib Improve PFS Compared to Chemo? Is Atezo+Nab-Paclitaxel Beneficial for OS/PFS? Should We Use Sacituzumab Govitecan in R/R Disease?

FEATURING Neelima Vidula
  • 72 views
  • March 9, 2021
  • 1
20:35

Virtual West Oncology Conference

2021 Update on EGFR Resistant NSCLC: How Effective Are Current Options? What Is the Role of ADCs?

FEATURING Shayma Kazmi
  • 503 views
  • March 8, 2021
  • 4
06:21

Virtual West Oncology Conference

ASH Updates on CAR-T in R/R DLBCL: When to Consider? Can It Be Used Earlier in High-Risk Patients or in First Salvage?

FEATURING Neha Mehta-Shah
  • 175 views
  • March 8, 2021
  • 1
07:20

Virtual West Oncology Conference

ASH Updates on Lymphomas: Bispecific Antibodies for Patients Who Relapse After CAR-T or ASCT, CAR-T & Bispecific Antibodies for Indolent Lymphomas

FEATURING Neha Mehta-Shah
  • 109 views
  • March 8, 2021
07:11

Virtual West Oncology Conference

ASH Updates on Relapsed/Refractory Hodgkin Lymphomas and PTCL: What Are Our Options?

FEATURING Neha Mehta-Shah
  • 25 views
  • March 8, 2021
30:58

Virtual West Oncology Conference

Non-Muscle Invasive Urothelial Carcinoma Case Disussion: 62 y/o Male With High-Grade Ta Disease - Risk Category, Chances of Recurrence/Progression, BCG-Refractory/BCG-Non-Responsive Differences, Role of RT, mUC Development

FEATURING Brad Somer, Daniel Vaena, Jean Hoffman-Censits, Amy Luckenbaugh, Holger Gieschen, Heather Greene
  • 210 views
  • March 7, 2021
  • 2
18:56

Virtual West Oncology Conference

Advanced NSCLC Case Expert Discussion: Incurable Recurrent Stage 3b Disease, KIF5B/RET+, After Concurrent CRT+Immune Checkpoint Inhibitor Maintenance

FEATURING Erminia Massarelli, Shayma Kazmi, Jason Porter, Erin Gillaspie, Katie Keane
  • 336 views
  • March 5, 2021
  • 1
13:35

Virtual West Oncology Conference

mNSCLC Case Expert Discussion: Left Lung SCC With Bone Metastases - Treating Oligometastatic Disease, EGFR TKI vs. IO

FEATURING Erminia Massarelli, Shayma Kazmi, Jason Porter, Erin Gillaspie, Katie Keane
  • 176 views
  • March 5, 2021
  • 1
15:58

Virtual West Oncology Conference

2021 Updates on mNCSLC: Single Agent IO and Combination Therapy Approaches in the 1L Setting

FEATURING Jason Porter
  • 351 views
  • March 5, 2021
  • 2
15:01

Virtual West Oncology Conference

2021 Updates on NMIBC: Low-Grade vs. High-Grade pTa, pT1, Carcinoma in Situ, Intravesical Chemo (Mitomycin C, Gemcitabine), BCG, Refractory High-Grade Disease

FEATURING Amy Luckenbaugh
  • 53 views
  • March 5, 2021
18:41

Virtual West Oncology Conference

2021 Updates in RCC: Surveying Data for SWOG 1500, Belzutifan, CLEAR, and CM9ER

FEATURING Brad Somer
  • 178 views
  • March 5, 2021
06:49

Virtual West Oncology Conference

Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Efficacy and Safety of Crizotinib, Sotorasib Data in KRAS G12C NSCLC

FEATURING Erminia Massarelli
  • 66 views
  • March 5, 2021
  • 2
16:08

Virtual West Oncology Conference

2021 Updates on RC: Does Neoadjuvant Chemo Improve Outcomes? Who Needs Surgery/Radiation?

FEATURING Noam Vanderwalde
  • 96 views
  • March 5, 2021
15:43

Virtual West Oncology Conference

2021 Update on ctDNA Analysis in Colorectal Cancer: Surveying Application in Adjuvant Treatment and Post-Treatment Response Settings

FEATURING Gregory Botta
  • 523 views
  • March 5, 2021
  • 3
14:54

Virtual West Oncology Conference

Borderline Resectable Pancreatic Cancer Updates: What Are the Anatomic/Non-Anatomic Considerations? Does RT Help and What Is the Appropriate Dose?

FEATURING Paxton Dickson
  • 26 views
  • March 5, 2021
22:30

Virtual West Oncology Conference

2021 Updates on Advanced Bladder Cancer: What Agents Are Available in the 1L Setting and Beyond? How Promising Are Novel Combinations?

FEATURING Jean Hoffman-Censits
  • 79 views
  • March 5, 2021
08:44

Virtual West Oncology Conference

2021 Update on ADT Intensification for mCSPC: What Are the Benefits & Survival Rates of Apalutamide? When It Should Be Administered for Better Outcomes?

FEATURING Daniel Vaena
  • 49 views
  • March 5, 2021
12:40

Virtual West Oncology Conference

2021 Highlights on PARPi for mCRPC & PSMA Imaging: What Is the Efficacy and PFS/OS Effect of Olaparib/Rucaparib? How Does PSMA PET/CT Impact SRT Planning?

FEATURING Daniel Vaena
  • 155 views
  • March 5, 2021
06:27

Virtual West Oncology Conference

Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approved Selpercatinib & Pralsetinib

FEATURING Erminia Massarelli
  • 76 views
  • March 4, 2021
05:28

Virtual West Oncology Conference

2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease

FEATURING Erminia Massarelli
  • 151 views
  • March 4, 2021